Skip to main content

Table 1 Male-female distribution of patients with non-small cell lung cancer

From: EGFR mutation frequency in Middle East and African non-small cell lung cancer patients: a systematic review and meta-analysis

Country

Author

Male, No (%)

Female, No. (%)

Overall

 

829 (68.2%)

386 (31.8%)

Lebanon

Naderi et al. [9]

123 (61.2%)

78 (38.8%)

Fakhruddin et al. [10]

72 (67.9%)

34 (32.1%)

Kattan et al. [11]

102 (59.8%)

68 (40.2%)

Egypt

Zaki et al. [12]

40 (80%)

10 (20%)

Turkey

Unal et al. [13]

41 (85.4%)

7 (14.6%)

Bircan et al. [14]

21 (84%)

4 (16%)

Saudi Arabia (SA)

Al-Kuraya et al. [15]

37 (78.7%)

10 (21.2%)

SA-UAE-Qatar

Jazieh et al. [16]

162 (70.4%)

68 (29.6%)

SA-UAE-Egypt

Jazieh et al. [17]

140 (69.7%)

61 (30.3%)

Morocco

Errihani et al. [18]

91 (66.4%)

46 (33.6%)